IP Library Granted Patent US 10,883,988
Granted Patent B2
US 10,883,988 · App. 15/141,384 · Granted Jan 5, 2021

Method and kit for immunological detection of

Inventors: Urao Nonaka (Numazu, JP); Toshiyuki Kitagawa (Numazu, JP)
Assignee: TAUNS CO., LTD.
G01N33/5695G01N33/543
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,883,988
App. No.
15/141,384
Granted
Jan 5, 2021
Kind
B2
Abstract

Definitive diagnosis and early start of treatment cannot be made for tuberculosis since conventional methods for detecting a Mycobacterium tuberculosis complex require a long time plus enormous labor and expense. Because detection is difficult to perform directly from a biological sample, if the biological sample contains no or a very small amount of the Mycobacterium tuberculosis complex-specific secretory protein, there is a risk infection with the Mycobacterium tuberculosis complex will be missed. The present method and a kit address these long-standing needs by more rapidly and conveniently detecting a Mycobacterium tuberculosis complex, without culturing a biological sample containing the Mycobacterium tuberculosis complex, in which a biological sample is subjected to a heat-treatment so as to extracellularly secrete a Mycobacterium tuberculosis complex-specific secretory protein, such as at least one of MPB70, ESAT-6, or CFP-10 and subjecting the resulting treated sample to an immunological measurement/assay.

Claims (27)

1. A method for detecting the presence of a Mycobacterium tuberculosis complex-specific protein in a heat-treated biological sample, the method comprising

subjecting a heat-treated biological sample to an immunological assay using an antibody to detect for the presence of the Mycobacterium tuberculosis complex-specific protein, wherein the Mycobacterium tuberculosis complex-specific protein is at least one selected from the group consisting of MPB70, ESAT-6, and CFP-10,

wherein said heat-treated biological sample to be immunologically assayed is obtained by subjecting a biological sample that may contain Mycobacterium tuberculosis complex to a heat-treatment for 15 to 60 minutes at a temperature of 40° C. to 60° C. to promote extracellular secretion of the Mycobacterium tuberculosis complex-specific protein by Mycobacterium tuberculosis complex that may be present in the biological sample.

2. A method for detecting the presence of a Mycobacterium tuberculosis complex-specific protein according to claim 1 , wherein the heat-treatment of the biological sample is carried out at 45° C. to 60° C.

3. A method for detecting the presence of a Mycobacterium tuberculosis complex-specific protein according to claim 1 , wherein the heat-treatment of the biological sample is carried out at 40° C. to 55° C.

4. A method for detecting the presence of Mycobacterium tuberculosis complex-specific protein according to claim 1 , wherein the biological sample is selected from the group consisting of sputum, bronchial secretion, pleural effusion, gastric juice, blood, spinal fluid, urine, feces, bronchial lavage fluid, and a tissue collected from the bronchus or the lung.

5. A method for detecting the presence of a Mycobacterium tuberculosis complex-specific protein according to claim 4 , wherein the biological sample is sputum.

6. A method for detecting the presence of a Mycobacterium tuberculosis complex-specific protein according to claim 1 , wherein the method further comprises treating the biological sample with a sample treating agent, before the biological sample is subjected to the heat-treatment, to lyse the biological sample, wherein said sample treating agent is selected from the group consisting of an alkaline substance, a reducing substance, a protease, a sugar, a surfactant and a protein denaturant.

7. A method for detecting the presence of a Mycobacterium tuberculosis complex-specific protein according to claim 6 , wherein, before being subjected to the heat-treatment, the biological sample treated with a sample treating agent is dispersed or dissolved in a solvent.

8. A method for detecting the presence of a Mycobacterium tuberculosis complex-specific protein according to claim 1 , wherein the immunological assay is a sandwich immunoassay using a first antibody and a second antibody against the Mycobacterium tuberculosis complex-specific secretory protein.

9. A method for detecting the presence of a Mycobacterium tuberculosis complex-specific protein according to claim 8 , wherein the immunological assay is an immunochromatographic assay.

10. A method for detecting the presence of a Mycobacterium tuberculosis complex-specific protein according to claim 8 , wherein the immunological assay is ELISA.

11. A kit for detection of the presence of a Mycobacterium tuberculosis complex-specific protein selected from the group consisting of MPB70, ESAT-6, and CFP-10, in a heat-treated biological sample comprising at least

a treatment container in which a biological sample to be tested for the presence of Mycobacterium tuberculosis complex-specific protein is subjected to a heat-treatment at 40° C. to 60° C. for 15 to 60 minutes, to promote Mycobacterium tuberculosis complex, if present in the biological sample, to extracellularly secrete the at least one Mycobacterium tuberculosis complex-specific protein selected from the group consisting of MPB70, ESAT-6, and CFP-10; and

an immunological assay apparatus using an antibody for detecting the presence of at least one secreted Mycobacterium tuberculosis complex-specific protein selected from the group consisting of MPB70, ESAT-6, and CFP-10 following the heat-treatment.

12. A kit for detection of the presence of a Mycobacterium tuberculosis complex-specific protein according to claim 11 , further comprising a sample treating agent and/or a solvent, wherein said sample treating agent is selected from the group consisting of an alkaline substance, a reducing substance, a protease, a sugar, a surfactant and a protein denaturant.

13. A kit for detection of the presence of a Mycobacterium tuberculosis complex-specific protein according to claim 11 , wherein the immunological assay apparatus is a sandwich immunoassay apparatus for detecting a Mycobacterium tuberculosis complex-specific protein using a first antibody and a second antibody against the Mycobacterium tuberculosis complex-specific secretory protein.

14. A kit for detection of the presence of a Mycobacterium tuberculosis complex-specific protein according to claim 11 , wherein the immunological assay apparatus is an immunochromatographic assay apparatus.

15. A kit for detection of the presence of a Mycobacterium tuberculosis complex-specific protein according to claim 11 , wherein the immunological assay apparatus is an ELISA assay apparatus.

16. A method for promoting extracellularly secreting a Mycobacterium tuberculosis complex-specific protein, comprising subjecting a biological sample containing the Mycobacterium tuberculosis complex to a heat-treatment at 40° C. to 60° C. for 15 to 60 minutes whereby said Mycobacterium tuberculosis complex-specific protein is extracellularly secreted and is at least one protein selected from the group consisting of MPB70, ESAT-6, and CFP-10.

17. A method for detecting the presence of a Mycobacterium tuberculosis complex-specific protein according to claim 6 , wherein the sample treating agent is at least one selected from the group consisting of NaOH and N-acetyl-L-cysteine.

18. A kit for detection of the presence of a Mycobacterium tuberculosis complex-specific protein according to claim 12 , wherein the kit includes at least one sample treating agent selected from the group consisting of NaOH and N-acetyl-L-cysteine.

19. A kit for detection of the presence of a Mycobacterium tuberculosis complex-specific protein according to claim 12 , wherein the immunological assay apparatus is a sandwich immunoassay apparatus using a first antibody and a second antibody against the at least one Mycobacterium tuberculosis complex-specific secretory protein.

20. A kit for detecting the presence of a Mycobacterium tuberculosis complex-specific protein selected from the group consisting of MPB70, ESAT-6, and CFP-10 in a heat-treated biological sample, comprising at least a treatment container in which a biological sample to be tested for the Mycobacterium tuberculosis complex-specific protein is subjected to a heat-treatment, wherein the treatment container is adapted to allow the biological sample to be heated at 40° C. to 60° C. for a time sufficient for Mycobacterium tuberculosis complex, if present in the biological sample, to extracellularly secrete the at least one Mycobacterium tuberculosis complex-specific protein selected from the group consisting of MPB70, ESAT-6, and CFP-10, said treatment container having an opening comprising a dropper nozzle and a filter for removing solid matter and discharging drops of heat-treated and filtered biological sample; and an immunological assay apparatus using an antibody for detecting the presence of at least one secreted Mycobacterium tuberculosis complex-specific protein selected from the group consisting of MPB70, ESAT-6, and CFP-10 in drops of filtered and heat-treated biological sample discharged from the treatment container following the heat-treatment.

21. A method for detecting the presence of a Mycobacterium tuberculosis complex-specific protein in a heat-treated biological sample as an indicator for the presence of Mycobacterium tuberculosis complex in the biological sample, the method comprising

subjecting a heat-treated biological sample to an immunological assay using an antibody to detect for the presence of the Mycobacterium tuberculosis complex-specific protein, wherein the Mycobacterium tuberculosis complex-specific protein is at least one selected from the group consisting of MPB70, ESAT-6, and CFP-10, wherein the detected presence of the at least one Mycobacterium tuberculosis complex-specific protein is an indicator for the presence of the Mycobacterium tuberculosis complex in the biological sample,

wherein said heat-treated biological sample to be immunologically assayed is obtained by collecting a biological sample that may contain Mycobacterium tuberculosis complex from a subject, the biological sample comprising biological sample selected from the group consisting of sputum, bronchial secretion, pleural effusion, gastric juice, blood, spinal fluid, urine, feces, bronchial lavage fluid, and a tissue collected from the bronchus or the lung; and subjecting the biological sample that may contain the Mycobacterium tuberculosis complex to a heat-treatment for a time sufficient 15 to 60 minutes at a temperature of 40° C. to 60° C. so as to promote the extracellular secretion of the Mycobacterium tuberculosis complex-specific protein by the Mycobacterium tuberculosis complex that may be present in the biological sample.

Assignments (4)
MERGER Recorded Nov 16, 2016
From: ARNO CO., LTD.
To: TAUNS CO., LTD.
Reel/Frame 040333/0156 →
MERGER Recorded Nov 15, 2016
From: BL CO., LTD.
To: ARNO CO., LTD.
Reel/Frame 040327/0311 →
MERGER Recorded Jun 21, 2016
From: ARNOTECH CO., LTD.
To: BL CO., LTD.
Reel/Frame 038976/0578 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2016
From: NONAKA, URAO; KITAGAWA, TOSHIYUKI
To: BL CO., LTD.
Reel/Frame 038976/0786 →
Priority Claims (1)
JP 2012-086566 · Apr 5, 2012 · national
Continuity (2)
Division 14390706
Related Publication 20160238599A1 · Aug 18, 2016